Sherbrooke Park Advisers’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-138,339	Closed	-$484K	–	896
2024 Q3	$484K	Buy	138,339 +109,687	+383%	+$384K	0.11%	323
2024 Q2	$94K	Buy	+28,652	New	+$94K	0.02%	842